New hope for pancreatic cancer? trial combines experimental drug with standard chemo
Disease control
Recruiting now
This study tests a new drug (KN510713) combined with standard chemotherapy (mFOLFIRINOX) in 30 adults with advanced pancreatic cancer that cannot be removed by surgery. The goal is to find the best dose and see if the combination is safe and shrinks tumors. Participants must not …
Phase: PHASE1, PHASE2 • Sponsor: New Cancer Cure-Bio Co.,Ltd. • Aim: Disease control
Last updated May 13, 2026 16:02 UTC